semaglutide binge eating disorder New hope for and bulimia: GLP-1 drugs could be the key All Categories - EAT LAB

Forest plot of GLP-1 receptor agonists versus comparators on the risk of Dyspnoea

Reduced appetite is the intended effect, though it sometimes feels too extreme

This interplay complicates the interpretation of GLP-1 RA efficacy and underscores the need for dedicated dermatology-focused trials

2016;310:E105361

Less than 2% of cases were reported hyperglycemia in linsitinib trials, which means it is safe for glucose management in diabetic pancreatic cancer patients

In susceptible populations such as the elderly, persistent hyperglycemia associated with GC use can precipitate hyperglycemic hyperosmolar states, which would require frequent hospital admissions for aggressive hydration and insulin therapy, as well as increased complications related to inpatient hyperglycemia[19]